Selected article for: "chprrsv group and UnVac UnCh group"

Author: Oh, Taehwan; Park, Kee Hwan; Yang, Siyeon; Jeong, Jiwoon; Kang, Ikjae; Park, Changhoon; Chae, Chanhee
Title: Evaluation of the efficacy of a trivalent vaccine mixture against a triple challenge with Mycoplasma hyopneumoniae, PCV2, and PRRSV and the efficacy comparison of the respective monovalent vaccines against a single challenge
  • Document date: 2019_10_16
  • ID: 0q0jon8j_14
    Snippet: The Vac3FLEX/Ch3 and VacPRRS/ChPRRSV groups had a significantly higher (P < 0.05) PRRSV ELISA S/P ratio compared to the UnVac/Ch3 and UnVac/ ChPRRSV groups from − 14 to 28 dpc. The UnVac/ ChPRRSV group had a significantly higher (P < 0.05) Fig. 1 a Mean respiratory scores between trivalent vaccine mixture and respective monovalent M. hyopneumoniae vaccine. b Mean respiratory scores between trivalent vaccine mixture and respective monovalent PCV.....
    Document: The Vac3FLEX/Ch3 and VacPRRS/ChPRRSV groups had a significantly higher (P < 0.05) PRRSV ELISA S/P ratio compared to the UnVac/Ch3 and UnVac/ ChPRRSV groups from − 14 to 28 dpc. The UnVac/ ChPRRSV group had a significantly higher (P < 0.05) Fig. 1 a Mean respiratory scores between trivalent vaccine mixture and respective monovalent M. hyopneumoniae vaccine. b Mean respiratory scores between trivalent vaccine mixture and respective monovalent PCV2 vaccine. c Mean respiratory scores between trivalent vaccine mixture and respective monovalent PRRS vaccine. Variation is expressed as the standard deviation. Different letters within a sampling point mean statistically significant differences (P < 0.05) PRRSV ELISA S/P ratio compared to the UnVac/Ch3 group at 7, 14, and 28 dpc (Fig. 3c) . No antibodies against M. hyopneumoniae, PCV2, and PRRSV were detected in any of the pigs from UnVac/UnCh group (Fig. 3c ). All pigs from all 9 groups were negative for influenza A virus antibodies.

    Search related documents:
    Co phrase search for related documents
    • chprrsv group and VacPRRS chprrsv: 1, 2
    • chprrsv group and VacPRRS chprrsv group: 1, 2
    • hyopneumoniae vaccine and monovalent hyopneumoniae vaccine: 1, 2, 3
    • hyopneumoniae vaccine and PRRS vaccine: 1
    • hyopneumoniae vaccine and respective monovalent: 1, 2, 3
    • hyopneumoniae vaccine and respective monovalent hyopneumoniae vaccine: 1
    • hyopneumoniae vaccine and trivalent vaccine: 1, 2, 3
    • hyopneumoniae vaccine and trivalent vaccine mixture: 1, 2, 3
    • influenza virus antibody and standard deviation: 1
    • influenza virus antibody and virus antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
    • monovalent hyopneumoniae vaccine and PRRS vaccine: 1
    • monovalent hyopneumoniae vaccine and respective monovalent: 1, 2
    • monovalent hyopneumoniae vaccine and respective monovalent hyopneumoniae vaccine: 1
    • monovalent hyopneumoniae vaccine and trivalent vaccine: 1, 2
    • monovalent hyopneumoniae vaccine and trivalent vaccine mixture: 1, 2
    • monovalent PRRS vaccine and PRRS vaccine: 1
    • monovalent PRRS vaccine and trivalent vaccine: 1
    • monovalent PRRS vaccine and trivalent vaccine mixture: 1
    • PRRS vaccine and respective monovalent: 1